Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Clinical trials for at-risk elderly people

Date added: 17 Jun 2020

Project should focus on multi-site clinical trials to address ageing-related issues such as reducing transmission, risk, morbidity, mortality, severity, or complications of COVID-19.

Amount
Not limited
Agency or Funder
National Institutes of Health and National Institute on Aging
Eligibility (if available)

Higher education institutions, nonprofits, for-profit organisations, local and federal governments, non-U.S entities, non-U.S. components of U.S. organisations

Foreign participation? (where known)
Yes
Date application deadline

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)

Existing grantholders wishing to expand the scope of their research.

Foreign participation? (where known)
Yes
Date application deadline

NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak

Date added: 23 Apr 2020

Research in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-2019).

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID
Eligibility (if available)

Grantees currently supported by active NIH (National Institute of Allergy and Infectius Diseases) funding

Date application deadline

Emergency competitive revisions for research on SARS-CoV-2 and COVID-19

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Existing NIAID grantholders

Date application deadline

Rapid response call for UK-led research into COVID-19

Date added: 29 Apr 2020

UKRI calls for projects with potential to deliver a significant contribution to the understanding, prevention or management of the COVID-19 outbreak within 12 months.

Amount
UK - 80% of full economic costs. Overseas - 100% direct costs only
Agency or Funder
UK Research and Innovation and the Department of Health and Social Care
Eligibility (if available)

Principal investigator must be hosted by an institution eligible for UKRI funding.

Foreign participation? (where known)
Yes
Date application deadline

Existing calls welcome proposals to develop medical countermeasures against SARS-CoV-2/COVID-19

Date added: 23 Apr 2020

NIAID announces that a number of existing calls will particularly welcome research objectives related to pathogenicity, transmission, medical countermeasures, pre-clinical testing of vaccines and therapeutics.

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Date application deadline